Yu Fujita
@jikeiexosome
Associate Prof. Div Next-Generat Drug Dev, The Jikei Univ Med, Tokyo & CTO, EVerMed Inc. ISEV Board at Large. Interested in #EV, #exosome, #fibrosis, #aging
ID: 1480739379044061188
https://www.jikei-exosome.com 11-01-2022 03:12:43
143 Tweet
138 Followers
373 Following
We publish a new study. Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular vesicles - Thoracic Cancer - onlinelibrary.wiley.com/doi/full/10.11…